Skip to main content

Cardiac remodeling and clinical effects of recombinant human acid alpha-glucosidase enzyme replacement therapy for infantile glycogen storage disease type II

Publication ,  Conference
Li, JS; Ing, RJ; Nozik-Grayck, E; Rice, H; Kravitz, RM; DeArmey, S; Mackey, J; Amalfitano, A; Chen, YT; Kishnani, P
Published in: CIRCULATION
October 26, 2004

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

October 26, 2004

Volume

110

Issue

17

Start / End Page

620 / 620

Location

New Orleans, LA

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

77th Scientific Meeting of the American-Heart-Association

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, J. S., Ing, R. J., Nozik-Grayck, E., Rice, H., Kravitz, R. M., DeArmey, S., … Kishnani, P. (2004). Cardiac remodeling and clinical effects of recombinant human acid alpha-glucosidase enzyme replacement therapy for infantile glycogen storage disease type II. In CIRCULATION (Vol. 110, pp. 620–620). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS.
Li, J. S., R. J. Ing, E. Nozik-Grayck, H. Rice, R. M. Kravitz, S. DeArmey, J. Mackey, A. Amalfitano, Y. T. Chen, and P. Kishnani. “Cardiac remodeling and clinical effects of recombinant human acid alpha-glucosidase enzyme replacement therapy for infantile glycogen storage disease type II.” In CIRCULATION, 110:620–620. LIPPINCOTT WILLIAMS & WILKINS, 2004.
Li JS, Ing RJ, Nozik-Grayck E, Rice H, Kravitz RM, DeArmey S, et al. Cardiac remodeling and clinical effects of recombinant human acid alpha-glucosidase enzyme replacement therapy for infantile glycogen storage disease type II. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2004. p. 620–620.
Li, J. S., et al. “Cardiac remodeling and clinical effects of recombinant human acid alpha-glucosidase enzyme replacement therapy for infantile glycogen storage disease type II.” CIRCULATION, vol. 110, no. 17, LIPPINCOTT WILLIAMS & WILKINS, 2004, pp. 620–620.
Li JS, Ing RJ, Nozik-Grayck E, Rice H, Kravitz RM, DeArmey S, Mackey J, Amalfitano A, Chen YT, Kishnani P. Cardiac remodeling and clinical effects of recombinant human acid alpha-glucosidase enzyme replacement therapy for infantile glycogen storage disease type II. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2004. p. 620–620.

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

October 26, 2004

Volume

110

Issue

17

Start / End Page

620 / 620

Location

New Orleans, LA

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

77th Scientific Meeting of the American-Heart-Association

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology